Menu
2004 Special Session I

Budget Amendments - HB5001 (Conference Report)

View Budget Item
View Budget Item amendments

Remove Biotech

Item C-196 #1c

Item C-196 #1c

First Year - FY2005 Second Year - FY2006
Central Appropriations
Central Capital Outlay FY2005 ($10,000,000) FY2006 $0 NGF

Language
Page 421, after line 45, insert:
"The Biotech Research Park Authority may examine the financial feasibility of using revenue supported bonds of the Virginia Public Building Authority to construct a commercial biotechnology facility."
Page 421, strike lines 46 through 55.
Page 422, strike lines 1 through 7.


Explanation
(This amendment removes general fund supported debt for a commercial biotechnology facility in the introduced budget and allows the Biotech Research Park Authority to examine the financial feasibility of using revenue bonds.)